International Journal of Hypertension / 2016 / Article / Tab 5

Research Article

An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy

Table 5

Estimates of the prevalence of CKD in the study population using the renal function equations.

Parameter4v-MDRDCGCKD-EPI

eGFR (mL/min/1.73 m2)TotalControlCaseTotalControlCaseTotalControlCase

Stage 1 (≥90)120 (49.80)57 (93.40)63 (35.00)136 (56.40)57 (93.40)79 (43.90)117 (48.50)59 (96.70)58 (32.20)
Stage 2 (60 to 89)89 (36.90)4 (6.60)85 (47.20)65 (27.00)4 (6.60)61 (33.90)89 (36.90)2 (3.30)87 (48.30)
Stage 3 (30 to 59)32 (13.30)0 (0.00)32 (17.80)39 (16.20)0 (0.00)39 (21.70)35 (14.50)0 (0.00)35 (14.50)
Stage 4 (15 to 29)0 (0.00)0 (0.00)0 (0.00)1 (0.40)0 (0.00)1 (0.60)0 (0.00)0 (0.00)0 (0.00)
Stage 5 (<15)0 (0.00)0 (0.00)0 (0.00)0 (0.00)0 (0.00)0 (0.00)0 (0.00)0 (0.00)0 (0.00)

CKD (Stages 3 + 4 + 5)32 (13.30)0 (0.00)32 (17.80)40 (16.60)0 (0.00)40 (22.22)35 (14.50)0 (0.00)35 (19.40)

Data is presented as absolute values with corresponding percentage in parenthesis. 4v-MDRD: four variable modification of diet in renal disease, CG: Cockcroft-Gault, CKD-EPI: chronic kidney disease epidemiology collaboration, eGFR: estimated glomerular filtration rate, and CKD: chronic kidney disease.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.